222
Views
61
CrossRef citations to date
0
Altmetric
Reviews

The role of blood pressure in glaucoma

, MBBS MOptom, , BSc(Optom) PhD PGCOT, , BOptom MOptom PhD & , BOptom MOptom PhD
Pages 133-149 | Received 15 Jul 2010, Accepted 12 Oct 2010, Published online: 15 Apr 2021

REFERENCES

  • Vingrys AJ. The many faces of glaucomatous optic neuropathy. Clin Exp Optom 2000; 83: 145–160.
  • Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389–393.
  • Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–851.
  • Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open‐angle glaucoma. Arch Ophthalmol 2002; 120: 701–713; discussion 829–730.
  • Flammer J. To what extent are vascular factors involved in the pathogensis of glaucoma?In: Kaiser HJ, Flammer J, Hendrickson P, eds.Ocular Blood Flow, New Insights into the Pathogenesis of Ocular Diseases. Basel, Switzerland: Karger AG, 1996.
  • Quigley HA. New paradigms in the mechanisms and management of glaucoma. Eye 2005; 19: 1241–1248.
  • Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open‐angle glaucoma. Arch Ophthalmol 2002; 120: 714–720; discussion 829–730.
  • Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121: 48–56.
  • Stefansson E, Pedersen DB, Jensen PK, La cour M, Kiilgaard JF, Bang K, Eysteinsson T. Optic nerve oxygenation. Prog Retin Eye Res 2005; 24: 307–332.
  • Stefansson E, Wagner HG, Seida M. Retinal blood flow and its autoregulation measured by intraocular hydrogen clearance. Exp Eye Res 1988; 47: 669–678.
  • Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open‐angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008; 115: 85–93.
  • Chen PP. Risk and risk factors for blindness from glaucoma. Curr Opin Ophthalmol 2004; 15: 107–111.
  • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262–267.
  • Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open‐angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996; 103: 1661–1669.
  • Wensor MD, Mccarty CA, Stanislavsky YL, Livingston PM, Taylor HR. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology 1998; 105: 733–739.
  • Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population‐based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001; 119: 1819–1826.
  • Balazsi AG, Rootman J, Drance SM, Schulzer M, Douglas GR. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol 1984; 97: 760–766.
  • Pearson PM, Schmidt LA, Ly‐schroeder E, Swanson WH. Ganglion cell loss and age‐related visual loss: a cortical pooling analysis. Optom Vis Sci 2006; 83: 444–454.
  • Kawai SI, Vora S, Das S, Gachie E, Becker B, Neufeld AH. Modeling of risk factors for the degeneration of retinal ganglion cells after ischemia/reperfusion in rats: effects of age, caloric restriction, diabetes, pigmentation, and glaucoma. Faseb J 2001; 15: 1285–1287.
  • Haegerstrom‐portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision function beyond acuity. Optom Vis Sci 1999; 76: 141–158.
  • Kong GY, Van bergen NJ, Trounce IA, Crowston JG. Mitochondrial dysfunction and glaucoma. J Glaucoma 2009; 18: 93–100.
  • Dallinger S, Findl O, Strenn K, Eichler HG, Wolzt M, Schmetterer L. Age dependence of choroidal blood flow. J Am Geriatr Soc 1998; 46: 484–487.
  • Harris A, Harris M, Biller J, Garzozi H, Zarfty D, Ciulla TA, Martin B. Aging affects the retrobulbar circulation differently in women and men. Arch Ophthalmol 2000; 118: 1076–1080.
  • Harris A, Jonescu‐cuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ. Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmol Scand 2001; 79: 336–341.
  • Katano H, Ishihara M, Shiraishi Y, Kawai Y. Effects of aging on the electroretinogram during ischemia‐reperfusion in rats. Jpn J Physiol 2001; 51: 89–97.
  • Matsuura K, Kawai Y. Effects of hypothermia and aging on postischemic reperfusion in rat eyes. Jpn J Physiol 1998; 48: 9–15.
  • Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol 2004; 122: 17–21.
  • Kim JW, Chen PP. Central corneal pachymetry and visual field progression in patients with open‐angle glaucoma. Ophthalmology 2004; 111: 2126–2132.
  • Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 136: 805–813.
  • Bellezza AJ, Hart RT, Burgoyne CF. The optic nerve head as a biomechanical structure: initial finite element modeling. Invest Ophthalmol Vis Sci 2000; 41: 2991–3000.
  • Burgoyne CF, Downs JC. Premise and prediction‐how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J Glaucoma 2008; 17: 318–328.
  • Jonas JB, Budde WM. Optic nerve damage in highly myopic eyes with chronic open‐angle glaucoma. Eur J Ophthalmol 2005; 15: 41–47.
  • Jonas JB, Gusek GC, Naumann GO. Optic disk morphometry in high myopia. Graefes Arch Clin Exp Ophthalmol 1988; 226: 587–590.
  • Jonas JB, Berenshtein E, Holbach L. Lamina cribrosa thickness and spatial relationships between intraocular space and cerebrospinal fluid space in highly myopic eyes. Invest Ophthalmol Vis Sci 2004; 45: 2660–2665.
  • Avetisov ES, Savitskaya NF, Vinetskaya MI, Iomdina EN. A study of biochemical and biomechanical qualities of normal and myopic eye sclera in humans of different age groups. Metab Pediatr Syst Ophthalmol 1983; 7: 183–188.
  • Gentle A, Liu Y, Martin JE, Conti GL, Mcbrien NA. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J Biol Chem 2003; 278: 16587–16594.
  • Mcbrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci 2000; 41: 3713–3719.
  • Leske MC, Connell AM, Wu SY, Hyman LG, Schachat AP. Risk factors for open‐angle glaucoma. The Barbados Eye Study. Arch Ophthalmol 1995; 113: 918–924.
  • Mitchell P, Hourihan F, Sandbach J, Wang JJ. The relationship between glaucoma and myopia: the Blue Mountains Eye Study. Ophthalmology 1999; 106: 2010–2015.
  • Xu L, Wang Y, Wang S, Wang Y, Jonas JB. High myopia and glaucoma susceptibility the Beijing Eye Study. Ophthalmology 2007; 114: 216–220.
  • Bonovas S, Peponis V, Filioussi K. Diabetes mellitus as a risk factor for primary open‐angle glaucoma: a meta‐analysis. Diabet Med 2004; 21: 609–614.
  • Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP. Type 2 diabetes mellitus and the risk of open‐angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology 2008; 115: 227–232.
  • Dielemans I, De jong PT, Stolk R, Vingerling JR, Grobbee DE, Hofman A. Primary open‐angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. The Rotterdam Study. Ophthalmology 1996; 103: 1271–1275.
  • Klein BE, Klein R, Jensen SC. Open‐angle glaucoma and older‐onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994; 101: 1173–1177.
  • Mitchell P, Smith W, Chey T, Healey PR. Open‐angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997; 104: 712–718.
  • Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, Hankinson SE. Prospective study of type 2 diabetes mellitus and risk of primary open‐angle glaucoma in women. Ophthalmology 2006; 113: 1081–1086.
  • De voogd S, Ikram MK, Wolfs RC, Jansonius NM, Witteman JC, Hofman A, De jong PT. Is diabetes mellitus a risk factor for open‐angle glaucoma? The Rotterdam Study. Ophthalmology 2006; 113: 1827–1831.
  • Kahn HA, Milton RC. Alternative definitions of open‐angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol 1980; 98: 2172–2177.
  • Ozcura F, Aydin S. Is diabetes mellitus a risk factor or a protector for primary open angle glaucoma? Med Hypotheses 2007; 69: 233–234.
  • Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open‐angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995; 102: 48–53.
  • Kanamori A, Nakamura M, Mukuno H, Maeda H, Negi A. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure. Curr Eye Res 2004; 28: 47–54.
  • Wong VHY, Bui BV, Vingrys AJ. Effect of acute intraocular pressure challenge on inner retinal function in diabetic rats. In: ARVO e‐Abstract 2761, 2009.
  • Alder VA, Su EN, Yu DY, Cringle SJ, Yu PK. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol 1997; 24: 785–788.
  • Do carmo A, Lopes C, Santos M, Proenca R, Cunha‐vaz J, Carvalho AP. Nitric oxide synthase activity and L‐arginine metabolism in the retinas from streptozotocin‐induced diabetic rats. Gen Pharmacol 1998; 30: 319–324.
  • Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end‐product formation. Diabetes 1993; 42: 221–232.
  • Wong VHY, Bui BV, Vingrys AJ. Clinical and experimental links between diabetes and glaucoma. Clin Exp Optom 2011; 94: 4–23.
  • Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP‐related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005; 24: 39–73.
  • Flammer J. Psychophysics in glaucoma: A modified concept of the disease. In: Greve EL, Leydhecker W, Raitta C, eds. European Glaucoma Society, Second European Glaucoma Symposium. Helsinki, 1984.
  • Van buskirk EM, Cioffi GA. Glaucomatous optic neuropathy. Am J Ophthalmol 1992; 113: 447–452.
  • Van buskirk EM, Cioffi GA. Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy. Am J Ophthalmol 1993; 116: 636–640.
  • Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977; 16: 426–441.
  • Pease ME, Mckinnon SJ, Quigley HA, Kerrigan‐baumrind LA, Zack DJ. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 2000; 41: 764–774.
  • Riva CE, Salgarello T, Logean E, Colotto A, Galan EM, Falsini B. Flicker‐evoked response measured at the optic disc rim is reduced in ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci 2004; 45: 3662–3668.
  • Schwartz B, Rieser JC, Fishbein SL. Fluorescein angiographic defects of the optic disc in glaucoma. Arch Ophthalmol 1977; 95: 1961–1974.
  • Zhao DY, Cioffi GA. Anterior optic nerve microvascular changes in humanglaucomatous optic neuropathy. Eye 2000; 14: 445–449.
  • Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res 2006; 25: 490–513.
  • Agar A, Li S, Agarwal N, Coroneo MT, Hill MA. Retinal ganglion cell line apoptosis induced by hydrostatic pressure. Brain Res 2006; 1086: 191–200.
  • Agar A, Yip SS, Hill MA, Coroneo MT. Pressure related apoptosis in neuronal cell lines. J Neurosci Res 2000; 60: 495–503.
  • Kloda A, Lua L, Hall R, Adams DJ, Martinac B. Liposome reconstitution and modulation of recombinant N‐methyl‐D‐aspartate receptor channels by membrane stretch. Proc Natl Acad Sci U S A 2007; 104: 1540–1545.
  • Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. The effects of acute intraocular pressure elevation on rat retinal glutamate transport. Acta Ophthalmol 2008; 86: 408–414.
  • Tezel G. The role of glia, mitochondria, and the immune system in glaucoma. Invest Ophthalmol Vis Sci 2009; 50: 1001–1012.
  • Bonomi L, Marchini G, Marraffa M, Bernardi P, Morbio R, Varotto A. Vascular risk factors for primary open angle glaucoma: the Egna‐Neumarkt Study. Ophthalmology 2000; 107: 1287–1293.
  • Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, De jong PT. Primary open‐angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995; 102: 54–60.
  • Klein BE, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005; 89: 284–287.
  • Mcleod SD, West SK, Quigley HA, Fozard JL. A longitudinal study of the relationship between intraocular and blood pressures. Invest Ophthalmol Vis Sci 1990; 31: 2361–2366.
  • Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open‐angle glaucoma. A population‐based assessment. Arch Ophthalmol 1995; 113: 216–221.
  • Vaajanen A, Mervaala E, Oksala O, Vapaatalo H. Is there a relationship between blood pressure and intraocular pressure? An experimental study in hypertensive rats. Curr Eye Res 2008; 33: 325–332.
  • Harrison JM, Kiel JW, Smith S. Effect of ocular perfusion pressure on retinal function in the rabbit. Vision Res 1997; 37: 2339–2347.
  • Carel RS, Korczyn AD, Rock M, Goya I. Association between ocular pressure and certain health parameters. Ophthalmology 1984; 91: 311–314.
  • Pederson JE, Green K. Aqueous humor dynamics: experimental studies. Exp Eye Res 1973; 15: 277–297.
  • Goldberg I, Hollows FC, Kass MA, Becker B. Systemic factors in patients with low‐tension glaucoma. Br J Ophthalmol 1981; 65: 56–62.
  • Hulsman CA, Vingerling JR, Hofman A, Witteman JC, De jong PT. Blood pressure, arterial stiffness, and open‐angle glaucoma: the Rotterdam study. Arch Ophthalmol 2007; 125: 805–812.
  • Kashiwagi K, Hosaka O, Kashiwagi F, Taguchi K, Mochizuki J, Ishii H, Ijiri H et al. Systemic circulatory parameters. Comparison between patients with normal tension glaucoma and normal subjects using ambulatory monitoring. Jpn J Ophthalmol 2001; 45: 388–396.
  • Leighton DA, Phillips CI. Systemic blood pressure in open‐angle glaucoma, low tension glaucoma, and the normal eye. Br J Ophthalmol 1972; 56: 447–453.
  • Levene RZ. Low tension glaucoma: a critical review and new material. Surv Ophthalmol 1980; 24: 621–664.
  • Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open‐angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma 2004; 13: 319–326.
  • Orzalesi N, Rossetti L, Omboni S. Vascular risk factors in glaucoma: the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007; 245: 795–802.
  • Rouhiainen HJ, Terasvirta ME. Hemodynamic variables in progressive and non‐progressive low tension glaucoma. Acta Ophthalmol (Copenh) 1990; 68: 34–36.
  • Wang N, Peng Z, Fan B, Liu Y, Dong X, Liang X, Luan J. [Case control study on the risk factors of primary open angle glaucoma in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23: 293–296.
  • Collignon N, Dewe W, Guillaume S, Collignon‐brach J. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol 1998; 22: 19–25.
  • Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica 1984; 188: 65–75.
  • Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol 1999; 43Suppl1: S10–S16.
  • Graham SL, Drance SM, Wijsman K, Douglas GR, Mikelberg FS. Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip. Ophthalmology 1995; 102: 61–69.
  • Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117: 603–624.
  • Kaiser HJ, Flammer J, Burckhardt D. Silent myocardial ischemia in glaucoma patients. Ophthalmologica 1993; 207: 6–7.
  • Kaiser HJ, Flammer J, Graf T, Stumpfig D. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1993; 231: 677–680.
  • Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long‐term progression in the early manifest glaucoma trial. Ophthalmology 2007; 114: 1965–1972.
  • Sachsenweger R. [The influence of hypertension on the prognosis of glaucoma.] Klin Monbl Augenheilkd 1963; 142: 625–633.
  • Topouzis F, Coleman AL, Harris A, Jonescu‐cuypers C, Yu F, Mavroudis L, Anastasopoulos E et al. Association of blood pressure status with the optic disk structure in non‐glaucoma subjects: the Thessaloniki eye study. Am J Ophthalmol 2006; 142: 60–67.
  • Kaiser HJ, Flammer J. Systemic hypotension: a risk factor for glaucomatous damage? Ophthalmologica 1991; 203: 105–108.
  • Choi J, Jeong J, Cho HS, Kook MS. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 831–836.
  • Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet 1987; 1: 581–584.
  • Somes GW, Pahor M, Shorr RI, Cushman WC, Applegate WB. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999; 159: 2004–2009.
  • Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J‐shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 1999; 34: 1181–1185.
  • Sommer A, Tielsch J. Blood pressure, perfusion pressure, and open‐angle glaucoma. Arch Ophthalmol 2008; 126: 741; author reply 741–742.
  • Memarzadeh F, Ying‐lai M, Chung J, Azen SP, Varma R. Blood pressure, perfusion pressure, and open‐angle glaucoma: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci 2010; 51: 2872–2877.
  • Dobree JH. Calibre changes in retinal vessels occurring in raised ocular tension; circulatory compensation in chronic glaucoma. Br J Ophthalmol 1956; 40: 1–13.
  • Russell RW. Evidence for autoregulation in human retinal circulation. Lancet 1973; 2: 1048–1050.
  • Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH. Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 1986; 27: 722–726.
  • Grosvenor T. Primary Care Optometry, 5th ed. Hong Kong: Butterworth–Heinemann Elsevier, 2006.
  • Lovasik JV, Kothe AC, Kergoat H. Comparison of noninvasive methods to derive the mean central retinal artery pressure in man. Optom Vis Sci 1993; 70: 1005–1011.
  • Bill A. Ocular circulation. In: Adler FH, Moses RA, eds.Adler's Physiology of the Eye. St Louis, Missouri: The CV Mosby Co, 1975. p215.
  • Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 2003; 135: 664–669.
  • Gehlbach PL, Purple RL. A paired comparison of two models of experimental retinal ischemia. Curr Eye Res 1994; 13: 597–602.
  • Grehn F, Prost M. Function of retinal nerve fibers depends on perfusion pressure: neurophysiologic investigations during acute intraocular pressure elevation. Invest Ophthalmol Vis Sci 1983; 24: 347–353.
  • Siliprandi R, Bucci MG, Canella R, Carmignoto G. Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cats. Invest Ophthalmol Vis Sci 1988; 29: 558–565.
  • Maffei L, Fiorentini A, Bisti S, Hollander H. Pattern ERG in the monkey after section of the optic nerve. Exp Brain Res 1985; 59: 423–425.
  • Kiel JW, Van heuven WA. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci 1995; 36: 579–585.
  • Liang Y, Downs JC, Fortune B, Cull G, Cioffi GA, Wang L. Impact of systemic blood pressure on the relationship between intraocular pressure and blood flow in the optic nerve head of nonhuman primates. Invest Ophthalmol Vis Sci 2009; 50: 2154–2160.
  • He Z, Vingrys AJ, Armitage JA, Bui BV. Effect of ocular perfusion pressure on retinal function in rats. In: ARVO e‐Abstract 2752‐D676. Ft Lauderdale, FL, USA, 2009.
  • Hayreh SS, Jonas JB, Zimmerman MB. Parapapillary chorioretinal atrophy in chronic high‐pressure experimental glaucoma in rhesus monkeys. Invest Ophthalmol Vis Sci 1998; 39: 2296–2303.
  • Hayreh SS, Pe'er J, Zimmerman MB. Morphologic changes in chronic high‐pressure experimental glaucoma in rhesus monkeys. J Glaucoma 1999; 8: 56–71.
  • Hill L, Flack M. The relation between capillary pressure and secretion. II. The secretion of the aqueous and the intraocular pressure. Proc Roy Soc B 1912; 85: 439.
  • Harino S, Riva CE, Petrig BL. Intravenous nicardipine in cats increases optic nerve head but not retinal blood flow. Invest Ophthalmol Vis Sci 1992; 33: 2885–2890.
  • Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res 1999; 69: 413–429.
  • Seligsohn EE, Bill A. Effects of NG‐nitro‐L‐arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin‐releasing hormone. Br J Pharmacol 1993; 109: 1219–1225.
  • Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro‐L‐arginine. J Cereb Blood Flow Metab 1996; 16: 981–987.
  • Riva CE, Petrig BL. Choroidal blood flow by laser Doppler flowmetry. Optical Engineering 1995; 34: 746–752.
  • Riva CE, Hero M, Titze P, Petrig B. Autoregulation of human optic nerve head blood flow in response to acute changes in ocular perfusion pressure. Graefes Arch Clin Exp Ophthalmol 1997; 235: 618–626.
  • Movaffaghy A, Chamot SR, Petrig BL, Riva CE. Blood flow in the human optic nerve head during isometric exercise. Exp Eye Res 1998; 67: 561–568.
  • Riva CE, Grunwald JE, Petrig BL. Autoregulation of human retinal blood flow. An investigation with laser Doppler velocimetry. Invest Ophthalmol Vis Sci 1986; 27: 1706–1712.
  • Dumskyj MJ, Eriksen JE, Dore CJ, Kohner EM. Autoregulation in the human retinal circulation: assessment using isometric exercise, laser Doppler velocimetry, and computer‐assisted image analysis. Microvasc Res 1996; 51: 378–392.
  • Harris A, Arend O, Bohnke K, Kroepfl E, Danis R, Martin B. Retinal blood flow during dynamic exercise. Graefes Arch Clin Exp Ophthalmol 1996; 234: 440–444.
  • Jeppesen P, Sanye‐hajari J, Bek T. Increased blood pressure induces a diameter response of retinal arterioles that increases with decreasing arteriolar diameter. Invest Ophthalmol Vis Sci 2007; 48: 328–331.
  • Riva CE, Titze P, Hero M, Petrig BL. Effect of acute decreases of perfusion pressure on choroidal blood flow in humans. Invest Ophthalmol Vis Sci 1997; 38: 1752–1760.
  • Polska E, Simader C, Weigert G, Doelemeyer A, Kolodjaschna J, Scharmann O, Schmetterer L. Regulation of choroidal blood flow during combined changes in intraocular pressure and arterial blood pressure. Invest Ophthalmol Vis Sci 2007; 48: 3768–3774.
  • Chemtob S, Beharry K, Rex J, Chatterjee T, Varma DR, Aranda JV. Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci 1991; 32: 1799–1807.
  • Chemtob S, Beharry K, Rex J, Varma DR, Aranda JV. Changes in cerebrovascular prostaglandins and thromboxane as a function of systemic blood pressure. Cerebral blood flow autoregulation of the newborn. Circ Res 1990; 67: 674–682.
  • Laties AM, Jacobowitz D. A comparative study of the autonomic innervation of the eye in monkey, cat and rabbit. Anat Rec 1966; 156: 383–395.
  • Ruskell GL. An ocular parasympathetic nerve pathway of facial nerve origin and its influence on intraocular pressure. Exp Eye Res 1970; 10: 319–330.
  • Alm A. Ocular circulation. In: Kaufman PL, Alm A, Adler FH, eds.Adler's physiology of the Eye: Clinical Application. 10thed.St Louis: Mosby, 2003.
  • Costa VP, Harris A, Stefansson E, Flammer J, Krieglstein GK, Orzalesi N, Heijl A et al. The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res 2003; 22: 769–805.
  • Lansman JB, Hallam TJ, Rink TJ. Single stretch‐activated ion channels in vascular endothelial cells as mechanotransducers? Nature 1987; 325: 811–813.
  • Delaey C, Van de voorde J. Pressure‐induced myogenic responses in isolated bovine retinal arteries. Invest Ophthalmol Vis Sci 2000; 41: 1871–1875.
  • Jean‐louis S, Lovasik JV, Kergoat H. Systemic hyperoxia and retinal vasomotor responses. Invest Ophthalmol Vis Sci 2005; 46: 1714–1720.
  • Riva CE, Grunwald JE, Sinclair SH. Laser Doppler velocimetry study of the effect of pure oxygen breathing on retinal blood flow. Invest Ophthalmol Vis Sci 1983; 24: 47–51.
  • Riva CE, Pournaras CJ, Tsacopoulos M. Regulation of local oxygen tension and blood flow in the inner retina during hyperoxia. J Appl Physiol 1986; 61: 592–598.
  • Pournaras C, Tsacopoulos M, Chapuis P. Studies on the role of prostaglandins in the regulation of retinal blood flow. Exp Eye Res 1978; 26: 687–697.
  • Tsacopoulos M, David NJ. The effect of arterial PCO2 on relative retinal blood flow in monkeys. Invest Ophthalmol 1973; 12: 335–347.
  • Formaz F, Riva CE, Geiser M. Diffuse luminance flicker increases retinal vessel diameter in humans. Curr Eye Res 1997; 16: 1252–1257.
  • Michelson G, Patzelt A, Harazny J. Flickering light increases retinal blood flow. Retina 2002; 22: 336–343.
  • Toda N, Nakanishi‐toda M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog Retin Eye Res 2007; 26: 205–238.
  • Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 1997; 115: 497–503.
  • Pellanda N, Flammer J, Haefliger IO. L‐NAME‐ and U 46619‐induced contractions in isolated porcine ciliary arteries versus vortex veins. Klin Monbl Augenheilkd 2001; 218: 366–369.
  • Dieguez G, Garcia JL, Fernandez N, Garcia‐villalon AL, Monge L, Gomez B. Role of NO in goat basal cerebral circulation and after vasodilatation to hypercapnia or brief ischemias. Am J Physiol 1993; 265: R1410–R1415.
  • Ortega mateo A, De artinano AA. Highlights on endothelins: a review. Pharmacol Res 1997; 36: 339–351.
  • Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin‐1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995; 39Suppl1: S49–S56.
  • Nicolela MT, Ferrier SN, Morrison CA, Archibald ML, Levatte TL, Wallace K, Chauhan BC et al. Effects of cold‐induced vasospasm in glaucoma: the role of endothelin‐1. Invest Ophthalmol Vis Sci 2003; 44: 2565–2572.
  • Henry E, Newby DE, Webb DJ, Hadoke PW, O'brien CJ. Altered endothelin‐1 vasoreactivity in patients with untreated normal‐pressure glaucoma. Invest Ophthalmol Vis Sci 2006; 47: 2528–2532.
  • Flammer J, Mozaffarieh M. Autoregulation, a balancing act between supply and demand. Can J Ophthalmol 2008; 43: 317–321.
  • Moore D, Harris A, Wudunn D, Kheradiya N, Siesky B. Dysfunctional regulation of ocular blood flow: A risk factor for glaucoma? Clin Ophthalmol 2008; 2: 849–861.
  • Blann AD, Waite MA. von Willebrand factor and soluble E‐selectin in hypertension: influence of treatment and value in predicting the progression of atherosclerosis. Coron Artery Dis 1996; 7: 143–147.
  • Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, Mikami H et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996; 132: 779–782.
  • Muiesan ML, Salvetti M, Monteduro C, Rizzoni D, Zulli R, Corbellini C, Brun C et al. Effect of treatment on flow‐dependent vasodilation of the brachial artery in essential hypertension. Hypertension 1999; 33: 575–580.
  • Harper SL, Bohlen HG. Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. Hypertension 1984; 6: 408–419.
  • Strandgaard S, Jones JV, Mackenzie ET, Harper AM. Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res 1975; 37: 164–167.
  • Jones JV, Fitch W, Mackenzie ET, Strandgaard S, Harper AM. Lower limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res 1976; 39: 555–557.
  • Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973; 1: 507–510.
  • Dintenfass L. Hyperviscosity in Hypertension. Sydney: Pergamon Press, 1981.
  • Fowkes FG, Lowe GD, Rumley A, Lennie SE, Smith FB, Donnan PT. The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74-years. Eur Heart J 1993; 14: 597–601.
  • Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 1981; 70: 1195–1202.
  • Tibblin G, Bergentz SE, Bjure J, Wilhelmsen L. Hematocrit, plasma protein, plasma volume, and viscosity in early hypertensive disease. Am Heart J 1966; 72: 165–176.
  • Hayashi T, Watabe H, Kudomi N, Kim KM, Enmi J, Hayashida K, Iida H. A theoretical model of oxygen delivery and metabolism for physiologic interpretation of quantitative cerebral blood flow and metabolic rate of oxygen. J Cereb Blood Flow Metab 2003; 23: 1314–1323.
  • Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, Ichiya Y et al. CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol 1992; 262: F737–F743.
  • Mountz JM, Liu HG, Deutsch G. Neuroimaging in cerebrovascular disorders: measurement of cerebral physiology after stroke and assessment of stroke recovery. Semin Nucl Med 2003; 33: 56–76.
  • Zheng Y, Martindale J, Johnston D, Jones M, Berwick J, Mayhew J. A model of the hemodynamic response and oxygen delivery to brain. Neuroimage 2002; 16: 617–637.
  • Ginsberg MD, Mela L, Wrobel‐kuhl K, Reivich M. Mitochondrial metabolism following bilateral cerebral ischemia in the gerbil. Ann Neurol 1977; 1: 519–527.
  • Rehncrona S, Mela L, Siesjo BK. Recovery of brain mitochondrial function in the rat after complete and incomplete cerebral ischemia. Stroke 1979; 10: 437–446.
  • Schutz H, Silverstein PR, Vapalahti M, Bruce DA, Mela L, Langfitt TW. Brain mitochondrial function after ischemia and hypoxia. I. Ischemia induced by increased intracranial pressure. Arch Neurol 1973; 29: 408–416.
  • Leske MC, Wu SY, Nemesure B, Hennis A. Incident open‐angle glaucoma and blood pressure. Arch Ophthalmol 2002; 120: 954–959.
  • Allen CMC, Lueck CJ, Dennis M. Neurological disease. In: Boon NA, Colledge NR, Walker BR, Hunter JAA, eds.Davidson's Principles and Practise of Medicine, 20thed.Edinburgh: Churchill Livingstone, 2006.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.